VIDRALA VIDRALA, S.A./ ES0183746314 /
| 2024-04-30 1:06:10 PM | Chg. +0.1000 | Volume | Bid1:06:10 PM | Ask2024-04-30 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 99.2000EUR | +0.10% | 13,293 Turnover: 1.32 mill. |
99.2000Bid Size: 40 | 99.4000Ask Size: 83 | 3.2 bill.EUR | 1.27% | 13.72 |
GlobeNewswire
1:15 PM
U.S. Energy Corp. Announces Its Participation in the EF Hutton Annual Global Conference
GlobeNewswire
1:08 PM
Chainswap Wins Polo Match Against Solana at Dubai's First Crypto Polo Cup Event in April 2024
GlobeNewswire
1:07 PM
Tellabs Launches FlexSym OLT2: Redefining Fiber Networking for Overlay and Tactical Applications
GlobeNewswire
1:05 PM
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
1:05 PM
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth St...
GlobeNewswire
1:05 PM
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on ...
GlobeNewswire
1:00 PM
PyroGenesis Kicks Off New European Distribution Strategy with Contract to Supply Spanish Aerospace E...
GlobeNewswire
1:00 PM
Atico Updates Mineral Reserves and Resources for the El Roble Mine in Colombia
GlobeNewswire
1:00 PM
ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patien...
GlobeNewswire
1:00 PM
Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq ...
GlobeNewswire
1:00 PM
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Ho...
GlobeNewswire
1:00 PM
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀...
GlobeNewswire
1:00 PM
Chinese Steel Producer Orders World’s Most Powerful Continuous Caster from Primetals Technologies
